Egalet Corp Company Profile (NASDAQ:EGLT)

About Egalet Corp

Egalet Corp logoEgalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company's products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company's product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company's product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company's product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company's product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EGLT
  • CUSIP:
Key Metrics:
  • Previous Close: $4.79
  • 50 Day Moving Average: $5.25
  • 200 Day Moving Average: $6.92
  • 52-Week Range: $24,614,000.00 - $4.34
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.64
  • P/E Growth: 0.00
  • Market Cap: $121.35M
  • Outstanding Shares: 24,614,000
  • Beta: 0.55
Profitability:
  • Net Margins: -251.79%
  • Return on Equity: -127.84%
  • Return on Assets: -51.10%
Debt:
  • Debt-to-Equity Ratio: 3.21%
  • Current Ratio: 4.36%
  • Quick Ratio: 4.30%
Additional Links:
Companies Related to Egalet Corp:

Analyst Ratings

Consensus Ratings for Egalet Corp (NASDAQ:EGLT) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $11.88 (140.87% upside)

Analysts' Ratings History for Egalet Corp (NASDAQ:EGLT)
Show:
DateFirmActionRatingPrice TargetDetails
1/24/2017Cantor FitzgeraldReiterated RatingBuy$15.00View Rating Details
1/10/2017GabelliDowngradeBuy -> HoldView Rating Details
1/11/2017JMP SecuritiesReiterated RatingOutperform$15.00View Rating Details
3/14/2016Janney Montgomery ScottInitiated CoverageNeutral$8.00View Rating Details
9/30/2015GuggenheimReiterated RatingBuy$24.00View Rating Details
8/7/2015Canaccord GenuityReiterated RatingBuyView Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Egalet Corp (NASDAQ:EGLT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017        
11/4/2016Q316($0.90)($1.10)$4.50 million$4.70 millionViewN/AView Earnings Details
8/4/2016Q216($0.82)($0.97)$3.83 million$3.45 millionViewN/AView Earnings Details
5/10/2016Q116($0.87)($0.76)$3.50 million$2.70 millionViewListenView Earnings Details
3/8/2016Q415($0.91)($0.28)$2.80 million$2.10 millionViewN/AView Earnings Details
11/4/2015Q315($0.90)($0.81)$1.62 million$1.30 millionViewN/AView Earnings Details
8/6/2015Q215($1.02)($0.98)$1.47 millionViewN/AView Earnings Details
5/7/2015($0.98)($1.02)ViewN/AView Earnings Details
3/25/2015Q414($0.69)($0.48)$5.64 millionViewN/AView Earnings Details
11/12/2014Q314($0.77)($0.63)ViewN/AView Earnings Details
8/12/2014Q214($0.42)($0.73)ViewN/AView Earnings Details
5/13/2014Q114($0.16)($1.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Egalet Corp (NASDAQ:EGLT)
Current Year EPS Consensus Estimate: $-3.70 EPS
Next Year EPS Consensus Estimate: $-3.00 EPS

Dividends

Dividend History for Egalet Corp (NASDAQ:EGLT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Egalet Corp (NASDAQ:EGLT)
Insider Ownership Percentage: 13.20%
Institutional Ownership Percentage: 69.79%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/3/2017Jeffrey M DaynoInsiderSell536$7.75$4,154.00View SEC Filing  
1/3/2017Paul VarkiSVPSell806$7.75$6,246.50View SEC Filing  
1/3/2017Stan MusialCFOSell13,480$7.73$104,200.40View SEC Filing  
12/30/2016Mark StrobeckCOOSell8,700$7.81$67,947.00View SEC Filing  
10/3/2016Paul VarkiSVPSell806$7.56$6,093.36View SEC Filing  
10/3/2016Robert S RadieInsiderSell15,000$7.47$112,050.00View SEC Filing  
10/3/2016Stan MusialCFOSell13,480$7.47$100,695.60View SEC Filing  
9/30/2016Jeffrey M DaynoInsiderSell536$7.69$4,121.84View SEC Filing  
9/30/2016Mark StrobeckCOOSell33,700$7.58$255,446.00View SEC Filing  
7/6/2016Robert S RadieCEOSell15,000$5.01$75,150.00View SEC Filing  
7/5/2016Robert S RadieCEOSell5,000$4.94$24,700.00View SEC Filing  
7/5/2016Stan MusialCFOSell13,480$5.06$68,208.80View SEC Filing  
7/1/2016Robert S RadieCEOSell5,000$5.07$25,350.00View SEC Filing  
7/1/2016Stan MusialCFOSell10,000$5.06$50,600.00View SEC Filing  
6/30/2016Jeffrey M DaynoInsiderSell536$4.65$2,492.40View SEC Filing  
4/5/2016Deanne F MelloyInsiderSell860$6.96$5,985.60View SEC Filing  
4/5/2016Robert S RadieCEOSell5,000$6.99$34,950.00View SEC Filing  
4/4/2016Robert S RadieCEOSell10,000$6.97$69,700.00View SEC Filing  
1/11/2016Robert S. RadieCEOSell10,000$9.65$96,500.00View SEC Filing  
1/6/2016Robert S. RadieCEOSell5,000$10.52$52,600.00View SEC Filing  
10/6/2015Deanne F MelloyInsiderSell860$11.42$9,821.20View SEC Filing  
10/1/2015Robert S RadieCEOSell15,000$12.27$184,050.00View SEC Filing  
10/1/2015Stan MusialCFOSell8,480$12.32$104,473.60View SEC Filing  
9/30/2015Mark StrobeckInsiderSell5,220$12.56$65,563.20View SEC Filing  
7/8/2015Robert S RadieCEOSell6,000$11.97$71,820.00View SEC Filing  
7/6/2015Robert S RadieCEOSell9,000$12.53$112,770.00View SEC Filing  
7/1/2015Mark StrobeckInsiderSell10,440$12.98$135,511.20View SEC Filing  
7/1/2015Stan MusialCFOSell8,480$13.20$111,936.00View SEC Filing  
4/1/2015Robert S RadieCEOSell11,130$11.25$125,212.50View SEC Filing  
2/3/2015Jeffrey M DaynoInsiderSell2,500$8.87$22,175.00View SEC Filing  
1/2/2015Mark StrobeckInsiderSell3,480$5.09$17,713.20View SEC Filing  
1/2/2015Robert S RadieCEOSell11,130$5.11$56,874.30View SEC Filing  
9/10/2014Robert S RadieCEOSell40,040$9.61$384,784.40View SEC Filing  
9/8/2014Robert S RadieCEOSell49,000$9.74$477,260.00View SEC Filing  
8/13/2014Mark StrobeckInsiderSell5,135$9.20$47,242.00View SEC Filing  
8/11/2014Mark StrobeckInsiderSell5,700$10.28$58,596.00View SEC Filing  
8/7/2014Mark StrobeckInsiderSell3,085$11.50$35,477.50View SEC Filing  
8/7/2014Stan MusialCFOSell13,920$11.05$153,816.00View SEC Filing  
2/11/2014Jean Francois FormelaDirectorBuy41,667$12.00$500,004.00View SEC Filing  
2/11/2014Life Science Ventures SunstoneMajor ShareholderBuy133,333$12.00$1,599,996.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Egalet Corp (NASDAQ:EGLT)
DateHeadline
4-traders.com logoPomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT (NASDAQ:EGLT)
www.4-traders.com - February 25 at 4:38 PM
prnewswire.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds ... - PR Newswire (press release) (NASDAQ:EGLT)
www.prnewswire.com - February 25 at 3:46 AM
News IconStock Check: Reviewing the Numbers for Egalet Corp (EGLT) - Davidson Register (NASDAQ:EGLT)
davidsonregister.com - February 25 at 3:46 AM
4-traders.com logoLundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
www.4-traders.com - February 24 at 10:45 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT (NASDAQ:EGLT)
us.rd.yahoo.com - February 24 at 10:45 PM
News IconTrading Scope: Checking the Levels for Egalet Corp (EGLT) - Baxter Review (NASDAQ:EGLT)
baxternewsreview.com - February 24 at 11:40 AM
finance.yahoo.com logoEgalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017 (NASDAQ:EGLT)
finance.yahoo.com - February 23 at 4:56 PM
News IconTechnical Study: Following Indicators for Egalet Corp (EGLT) - Rives Journal (NASDAQ:EGLT)
rivesjournal.com - February 23 at 3:19 AM
businesswire.com logoEGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong ... - Business Wire (press release) (NASDAQ:EGLT)
www.businesswire.com - February 23 at 3:19 AM
businesswire.com logoEGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March ... (NASDAQ:EGLT)
www.businesswire.com - February 22 at 5:12 PM
News IconEgalet Corp EGLT Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:EGLT)
www.bioportfolio.com - February 22 at 5:12 PM
finance.yahoo.com logoEGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017 (NASDAQ:EGLT)
finance.yahoo.com - February 22 at 5:12 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation ... - Yahoo Finance (NASDAQ:EGLT)
finance.yahoo.com - February 22 at 7:27 AM
globenewswire.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100000 From ... - GlobeNewswire (press release) (NASDAQ:EGLT)
globenewswire.com - February 22 at 7:27 AM
News IconLooking Ahead for Egalet Corporation (NASDAQ:EGLT); Are These Shares Ready to Go Higher? - Aiken Advocate (NASDAQ:EGLT)
aikenadvocate.com - February 22 at 7:27 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet ... - Yahoo Finance (NASDAQ:EGLT)
finance.yahoo.com - February 22 at 7:27 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
finance.yahoo.com - February 22 at 7:27 AM
feeds.benzinga.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation (EGLT) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (NASDAQ:EGLT)
feeds.benzinga.com - February 21 at 3:54 PM
News IconNASDAQ:EGLT Investor Alert: Lawsuit alleges Misleading Statements by Egalet Corp (NASDAQ:EGLT)
www.groundreport.com - February 20 at 4:33 PM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
finance.yahoo.com - February 20 at 11:24 AM
feeds.benzinga.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) & Lead Plaintiff Deadline: March 28, 2017 (NASDAQ:EGLT)
feeds.benzinga.com - February 20 at 10:33 AM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with ... - Yahoo Finance (NASDAQ:EGLT)
finance.yahoo.com - February 18 at 4:37 PM
globenewswire.com logoEGLT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet ... - GlobeNewswire (press release) (NASDAQ:EGLT)
globenewswire.com - February 18 at 4:37 PM
4-traders.com logoKhang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
www.4-traders.com - February 18 at 9:59 AM
us.rd.yahoo.com logoEGLT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017 (NASDAQ:EGLT)
us.rd.yahoo.com - February 17 at 6:12 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline: March 28, 2017 (NASDAQ:EGLT)
us.rd.yahoo.com - February 16 at 9:02 PM
News IconAnalysts Weigh in on Egalet Corporation (NASDAQ:EGLT) - Rockville Register (NASDAQ:EGLT)
rockvilleregister.com - February 16 at 4:02 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
finance.yahoo.com - February 14 at 5:50 PM
News IconTechnical Roundup on Shares of Egalet Corp (EGLT) - Baldwin Journal (NASDAQ:EGLT)
baldwinjournal.com - February 14 at 3:45 AM
globenewswire.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Egalet Corporation and ... - GlobeNewswire (press release) (NASDAQ:EGLT)
globenewswire.com - February 14 at 3:45 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation (NASDAQ:EGLT)
finance.yahoo.com - February 13 at 5:40 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Egalet Corporation and Certain Officers – EGLT (NASDAQ:EGLT)
finance.yahoo.com - February 13 at 5:40 PM
businesswire.com logoEGLT LOSS NOTICE: Rosen Law Firm Reminds Egalet Corporation Investors of Important Deadline in Class Action ... - Business Wire (press release) (NASDAQ:EGLT)
www.businesswire.com - February 10 at 5:25 PM
News IconLawsuit for Investors in Shares of Egalet Corp (NASDAQ:EGLT) Seeks to Recover Losses (NASDAQ:EGLT)
www.digitaljournal.com - February 9 at 5:29 PM
finance.yahoo.com logoEGLT LOSS NOTICE: Rosen Law Firm Reminds Egalet Corporation Investors of Important Deadline in Class Action – EGLT (NASDAQ:EGLT)
finance.yahoo.com - February 8 at 10:27 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
finance.yahoo.com - February 8 at 10:27 PM
businesswire.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation To Contact Brower Piven Before The Lead ... (NASDAQ:EGLT)
www.businesswire.com - February 8 at 5:25 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline: March 28, 2017 (NASDAQ:EGLT)
finance.yahoo.com - February 8 at 5:25 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (NASDAQ:EGLT)
finance.yahoo.com - February 8 at 5:25 PM
baystreet.ca logoLevi & Korsinsky Files in U.S. District Court to Recover Losses Suffered by Investors in Egalet (EGLT) (NASDAQ:EGLT)
ir.baystreet.ca - February 7 at 6:04 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
finance.yahoo.com - February 3 at 10:19 PM
finance.yahoo.com logoEGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Egalet ... - Yahoo Finance (NASDAQ:EGLT)
finance.yahoo.com - February 3 at 5:18 PM
feeds.benzinga.com logoEGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017 (NASDAQ:EGLT)
feeds.benzinga.com - February 3 at 12:49 PM
einnews.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Egalet ... - U.S. Politics Today (NASDAQ:EGLT)
www.einnews.com - February 2 at 5:24 PM
businesswire.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation ... - Business Wire (press release) (NASDAQ:EGLT)
www.businesswire.com - February 2 at 5:24 PM
einnews.com logoB.C. man sentenced to 14 years in prison for trafficking fentanyl (NASDAQ:EGLT)
uspolitics.einnews.com - February 1 at 5:29 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:EGLT)
finance.yahoo.com - February 1 at 5:29 PM
einnews.com logoTrump Aide’s Deal With Chinese Firm Raises Fear of Tangled Interests (NASDAQ:EGLT)
uspolitics.einnews.com - January 31 at 10:38 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation (EGLT) To Contact Brower Piven Before The Lead Plaintiff Deadline (NASDAQ:EGLT)
finance.yahoo.com - January 31 at 10:38 PM
4-traders.com logoRosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation – EGLT (NASDAQ:EGLT)
www.4-traders.com - January 31 at 5:36 PM

Social

What is Egalet Corp's stock symbol?

Egalet Corp trades on the NASDAQ under the ticker symbol "EGLT."

Where is Egalet Corp's stock going? Where will Egalet Corp's stock price be in 2017?

4 brokers have issued 12-month price targets for Egalet Corp's shares. Their forecasts range from $8.00 to $15.00. On average, they anticipate Egalet Corp's share price to reach $11.88 in the next twelve months.

When will Egalet Corp announce their earnings?

Egalet Corp is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.

What are analysts saying about Egalet Corp stock?

Here are some recent quotes from research analysts about Egalet Corp stock:

  • Cantor Fitzgerald analysts commented, "Does the Label Differentiate? In the ADF morphine space there are already two approved products. ARYMO will launch with the label of IV abuse deterrence with the oral data. Though the IV label will be unique to ARYMO, we don’t believe that physicians or payors will be that explicit in differentiation. Embeda covers both oral and nasal with MorphaBond covering nasal only. Even with ARYMO expected to get nasal added to the label in 2018, no currently approved morphine ADF covers all routes. Our research, though limited due to few launches, seems to favor a comprehensive label in the conversion strategy. Tapering Launch Expectations: We are tapering our launch expectations around ARYMO as we see a more difficult commercial path given the ARYMO label. In a promotionally sensitive space like pain, a small sales force like EGLT’s may struggle for voice." (1/24/2017)

  • According to Zacks Investment Research, "Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in the developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications. Its principal product candidate consist of Egalet-001, is an abuse-deterrent, extended-release, oral morphine formulation in development for the treatment of moderate to severe pain, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation in development for the treatment of moderate to severe pain and Egalet-003 which are in pre-clinical trials. Egalet Corporation is based in City of Westminster, United Kingdom. " (1/13/2017)

Who owns Egalet Corp stock?

Egalet Corp's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (15.27%), Franklin Resources Inc. (11.10%), Federated Investors Inc. PA (9.67%), State Street Corp (1.30%), EcoR1 Capital LLC (0.90%) and Wall Street Associates (0.60%). Company insiders that own Egalet Corp stock include Deanne F Melloy, Jeffrey M Dayno, Mark Strobeck, Paul Varki, Robert S Radie and Stan Musial.

Who sold Egalet Corp stock? Who is selling Egalet Corp stock?

Egalet Corp's stock was sold by a variety of institutional investors in the last quarter, including Wall Street Associates. Company insiders that have sold Egalet Corp stock in the last year include Deanne F Melloy, Jeffrey M Dayno, Mark Strobeck, Paul Varki, Robert S Radie and Stan Musial.

Who bought Egalet Corp stock? Who is buying Egalet Corp stock?

Egalet Corp's stock was acquired by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Federated Investors Inc. PA, EcoR1 Capital LLC, State Street Corp, Flinton Capital Management LLC, Marshall Wace LLP, Tyers Asset Management LLC and Raymond James Financial Services Advisors Inc..

How do I buy Egalet Corp stock?

Shares of Egalet Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Egalet Corp stock cost?

One share of Egalet Corp stock can currently be purchased for approximately $4.93.

Egalet Corp (NASDAQ:EGLT) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Egalet Corp (NASDAQ:EGLT)

Earnings History Chart

Earnings by Quarter for Egalet Corp (NASDAQ:EGLT)

Dividend History Chart

Dividend Payments by Quarter for Egalet Corp (NASDAQ:EGLT)

Last Updated on 2/26/2017 by MarketBeat.com Staff